Clinical Trial Update: Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated reinfusion of autologous lymphocytes during immune suppression to treat metastatic melanoma; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Autologous lymphocyte infusion (autologous lymphocyte infusion)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma, Neoplasm Metastasis | Phase 2 | Status: COMPLETED | Results posted: 2012-12-21